{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:54:02Z","timestamp":1793224442915,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2021-00694"],"award-info":[{"award-number":["JPND2021-00694"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-1003"],"award-info":[{"award-number":["UKDRI-1003"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-01018"],"award-info":[{"award-number":["2022-01018"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019\\u201302397"],"award-info":[{"award-number":["2019\\u201302397"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-00356"],"award-info":[{"award-number":["2023-00356"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860197"],"award-info":[{"award-number":["860197"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","award":["#FO2022-0270"],"award-info":[{"award-number":["#FO2022-0270"]}],"id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201809\\u20132016862"],"award-info":[{"award-number":["201809\\u20132016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025294","name":"Research Ireland","doi-asserted-by":"publisher","award":["17\/FRL\/4860"],"award-info":[{"award-number":["17\/FRL\/4860"]}],"id":[{"id":"10.13039\/501100025294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019418","name":"NIHR Maudsley Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021720","name":"Olav Thon Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101053962"],"award-info":[{"award-number":["101053962"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["-71320"],"award-info":[{"award-number":["-71320"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbih.2026.101179","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:00:51Z","timestamp":1768410051000},"page":"101179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Systemic inflammation and its associations in acute moderate-severe Traumatic Brain Injury: a cross-sectional study"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7339-4854","authenticated-orcid":false,"given":"Lucia M.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-6409","authenticated-orcid":false,"given":"Eleftheria","family":"Kodosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe J.Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Heslegrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S.N.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl A.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Garbero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Magnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Loane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbih.2026.101179_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.bbih.2026.101179_bib2","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease \u2014 a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.bbih.2026.101179_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/jim-2016-000062","article-title":"Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity","volume":"64","author":"Boga","year":"2016","journal-title":"J. Invest. Med."},{"issue":"3","key":"10.1016\/j.bbih.2026.101179_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/02699052.2017.1418907","article-title":"A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury","volume":"32","author":"Bradley-Whitman","year":"2018","journal-title":"Brain Inj."},{"key":"10.1016\/j.bbih.2026.101179_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2011.20","article-title":"Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology","volume":"1","author":"Braunewell","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbih.2026.101179_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2014.09.004","article-title":"IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy","volume":"31","author":"Cayrol","year":"2014","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.bbih.2026.101179_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1373\/clinchem.2012.191106","article-title":"Soluble ST2 is associated with all-cause and cardiovascular mortality in a population-based cohort: the Dallas heart Study","volume":"59","author":"Chen","year":"2013","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bbih.2026.101179_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-022-01729-7","article-title":"Multiplex assessment of Serum chemokines CCL2, CCL5, CXCL1, CXCL10, and CXCL13 following traumatic brain injury","volume":"46","author":"Chen","year":"2023","journal-title":"Inflammation"},{"issue":"21\u201322","key":"10.1016\/j.bbih.2026.101179_bib9","article-title":"Interleukin-6 in traumatic brain injury: a janus-faced player in damage and repair","volume":"40","author":"Ciryam","year":"2023","journal-title":"J. Neurotrauma"},{"issue":"4","key":"10.1016\/j.bbih.2026.101179_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ana.24367","article-title":"Prediction of brain age suggests accelerated atrophy after traumatic brain injury","volume":"77","author":"Cole","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbih.2026.101179_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2018.09.035","article-title":"Serum ST2 as a potential prognostic biomarker for traumatic brain injury","volume":"487","author":"Du","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.bbih.2026.101179_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02634-4","article-title":"Neuronal nuclear calcium signaling suppression of microglial reactivity is mediated by osteoprotegerin after traumatic brain injury","volume":"19","author":"Fr\u00f6hlich","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbih.2026.101179_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2017.02.015","article-title":"Moderate blast exposure results in increased IL-6 and TNF\u03b1 in peripheral blood","volume":"65","author":"Gill","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.bbih.2026.101179_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042093","article-title":"Multicentre longitudinal study of fluid and neuroimaging BIOmarkers of AXonal injury after traumatic brain injury: the BIO-AX-TBI study protocol","volume":"10","author":"Graham","year":"2020","journal-title":"BMJ Open"},{"issue":"613","key":"10.1016\/j.bbih.2026.101179_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg9922","article-title":"Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury","volume":"13","author":"Graham","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.bbih.2026.101179_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.50499","article-title":"Traumatic brain injury and risk of incident comorbidities","volume":"7","author":"Halabi","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.bbih.2026.101179_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/jcbfm.2014.23","article-title":"Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial","volume":"34","author":"Helmy","year":"2014","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bbih.2026.101179_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2020.04.011","article-title":"Soluble ST2: a complex and diverse role in several diseases","volume":"507","author":"Homsak","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbih.2026.101179_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-8-171","article-title":"Neuroinflammation in Alzheimer's disease wanes with age","volume":"8","author":"Hoozemans","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.bbih.2026.101179_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(23)00241-7","article-title":"Long-term risk of cardiovascular disease after traumatic brain injury: screening and prevention","volume":"22","author":"Izzy","year":"2023","journal-title":"Lancet Neurol."},{"issue":"14","key":"10.1016\/j.bbih.2026.101179_bib21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1089\/neu.2013.3169","article-title":"Activation of NF-\u03baB mediates Astrocyte swelling and brain edema in traumatic brain injury","volume":"31","author":"Jayakumar","year":"2014","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.bbih.2026.101179_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/HTR.0000000000000031","article-title":"Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury","volume":"30","author":"Juengst","year":"2015","journal-title":"J. Head Trauma Rehabil."},{"issue":"9","key":"10.1016\/j.bbih.2026.101179_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(22)00256-3","article-title":"Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study","volume":"21","author":"Korley","year":"2022","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.bbih.2026.101179_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/HTR.0000000000000067","article-title":"Chronic inflammation after severe traumatic brain injury: characterization and associations with outcome at 6 and 12 months postinjury","volume":"30","author":"Kumar","year":"2015","journal-title":"J. Head Trauma Rehabil."},{"key":"10.1016\/j.bbih.2026.101179_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2014.12.021","article-title":"Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome","volume":"45","author":"Kumar","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2026.101179_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2015.12.008","article-title":"Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury","volume":"53","author":"Kumar","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.bbih.2026.101179_bib27","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2006.070912","article-title":"Identification of novel brain biomarkers","volume":"52","author":"Laterza","year":"2006","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.bbih.2026.101179_bib28","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The Nuclear Factor NF- B pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"11","key":"10.1016\/j.bbih.2026.101179_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012197","article-title":"Traumatic brain injury in England and Wales: prospective audit of epidemiology, complications and standardised mortality","volume":"6","author":"Lawrence","year":"2016","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.bbih.2026.101179_bib30","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2008.104497","article-title":"The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients","volume":"54","author":"Lee","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbih.2026.101179_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.03.005","article-title":"Inflammatory and anti-inflammatory cytokines bidirectionally modulate amygdala circuits regulating anxiety","volume":"188","author":"Lee","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bbih.2026.101179_bib32","doi-asserted-by":"crossref","unstructured":"Li LM, Kodosaki E, Heslegrave A, Soreq E, Nattino G, Garbero E, Zimmerman KA, Graham NSN, Moro F, Novelli D, Gradisek P, Magnoni S, Zetterberg H, Bertolini G, Sharp DJ. Acute Plasma VEGF-A Levels are Associated with Raised Intracranial Pressure and Chronic Lesion Volume After Traumatic Brain Injury. Published online February 21, 2025. doi:10.1101\/2025.02.17.25322293.","DOI":"10.1101\/2025.02.17.25322293"},{"key":"10.1016\/j.bbih.2026.101179_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2016.02.032","article-title":"The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury","volume":"144","author":"Li","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.bbih.2026.101179_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbih.2026.101179_bib35","article-title":"High-dimensional proteomic analysis for pathophysiological classification of traumatic brain injury","author":"Li","year":"2024","journal-title":"Brain"},{"issue":"MAR","key":"10.1016\/j.bbih.2026.101179_bib36","article-title":"VSNL1 co-expression networks in aging include calcium signaling, synaptic plasticity, and Alzheimer's disease pathways","volume":"6","author":"Lin","year":"2015","journal-title":"Front. Psychiatr."},{"issue":"6","key":"10.1016\/j.bbih.2026.101179_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-023-01421-0","article-title":"Interleukin-1 receptor antagonist as therapy for traumatic brain injury","volume":"20","author":"Lindblad","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.bbih.2026.101179_bib38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/brain\/awae350","article-title":"Exploiting blood-based biomarkers to align preclinical models with human traumatic brain injury","volume":"148","author":"Lisi","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.bbih.2026.101179_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.bbih.2026.101179_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-023-01555-4","article-title":"Exogenous interleukin 33 enhances the brain's lymphatic drainage and toxic protein clearance in acute traumatic brain injury mice","volume":"11","author":"Liu","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"issue":"DEC","key":"10.1016\/j.bbih.2026.101179_bib41","article-title":"A systematic review of the usefulness of glial fibrillary acidic protein for predicting acute intracranial lesions following head trauma","volume":"8","author":"Luoto","year":"2017","journal-title":"Front. Neurol."},{"issue":"September","key":"10.1016\/j.bbih.2026.101179_bib42","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1089\/neu.2006.0245","article-title":"The Mayo classification System for traumatic brain injury","volume":"1424","author":"Malec","year":"2007","journal-title":"J. Neurotrauma"},{"issue":"11","key":"10.1016\/j.bbih.2026.101179_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2013-307279","article-title":"Mortality and morbidity 15 years after hospital admission with mild head injury: a prospective case-controlled population study","volume":"85","author":"McMillan","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbih.2026.101179_bib44","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1096\/fj.201700826R","article-title":"IKK2\/NF\u2010\u03baB signaling protects neurons after traumatic brain injury","volume":"32","author":"Mettang","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.bbih.2026.101179_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbi.2025.01.002","article-title":"Advancing precision psychiatry and targeted treatments: insights from immunopsychiatry","volume":"125","author":"Miller","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.bbih.2026.101179_bib46","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/neu.1999.16.1023","article-title":"Prolonged activation of NF-\u03baB following traumatic brain injury in rats","volume":"16","author":"NONAKA","year":"1999","journal-title":"J. Neurotrauma"},{"issue":"5","key":"10.1016\/j.bbih.2026.101179_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s10143-022-01827-y","article-title":"Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: a systematic review","volume":"45","author":"Ooi","year":"2022","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.bbih.2026.101179_bib48","series-title":"Biomarkers of Aging Challenge Proteomics","author":"Poganik","year":"2024"},{"issue":"13","key":"10.1016\/j.bbih.2026.101179_bib49","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1089\/neu.2017.5399","article-title":"Chronic alterations in systemic immune function after traumatic brain injury","volume":"35","author":"Ritzel","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.bbih.2026.101179_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000001349","article-title":"Acute inflammation in traumatic brain injury and polytrauma patients using network analysis","volume":"53","author":"Rowland","year":"2020","journal-title":"Shock"},{"key":"10.1016\/j.bbih.2026.101179_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105310","article-title":"Parsimonious immune-response endotypes and global outcome in patients with traumatic brain injury","volume":"108","author":"Samanta","year":"2024","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bbih.2026.101179_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02654-0","article-title":"Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury","volume":"19","author":"Shultz","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbih.2026.101179_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2017.08.005","article-title":"Treatment with an interleukin-1 receptor antagonist mitigates neuroinflammation and brain damage after polytrauma","volume":"66","author":"Sun","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"October 2020","key":"10.1016\/j.bbih.2026.101179_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbi.2021.01.026","article-title":"Treelet transform analysis to identify clusters of systemic inflammatory variance in a population with moderate-to-severe traumatic brain injury","volume":"95","author":"Vijapur","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"3 APR","key":"10.1016\/j.bbih.2026.101179_bib55","article-title":"Altered calcium signaling following traumatic brain injury","author":"Weber","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"105","key":"10.1016\/j.bbih.2026.101179_bib56","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal."},{"issue":"8","key":"10.1016\/j.bbih.2026.101179_bib57","doi-asserted-by":"crossref","DOI":"10.1089\/neu.1998.15.573","article-title":"Structured interviews for the Glasgow outcome Scale and the Extended Glasgow Outcome Scale: guidelines for their use","volume":"15","author":"WILSON","year":"1998","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbih.2026.101179_bib58","article-title":"The role of markers of inflammation in traumatic brain injury","volume":"4 MAR","author":"Woodcock","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbih.2026.101179_bib59","article-title":"IL-33\/ST2 axis protects against traumatic brain injury through enhancing the function of regulatory T cells","volume":"13","author":"Xie","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbih.2026.101179_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-022-01208-z","article-title":"Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation","volume":"23","author":"Yshii","year":"2022","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.bbih.2026.101179_bib61","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-019-00749-6","article-title":"Geniposide alleviates traumatic brain injury in rats via anti-inflammatory effect and MAPK\/NF-kB inhibition","volume":"40","author":"Yuan","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101179_bib62","article-title":"Neuroinflammatory biomarkers for traumatic brain injury diagnosis and prognosis: a TRACK-TBI pilot Study","volume":"4","author":"Yue","year":"2023","journal-title":"Neurotrauma Rep."},{"issue":"11","key":"10.1016\/j.bbih.2026.101179_bib63","article-title":"High-dimensional spatial normalization of diffusion tensor images improves the detection of white matter differences: an example study using amyotrophic lateral sclerosis","volume":"26","author":"Zhang","year":"2007","journal-title":"IEEE Trans. Med. Imag."},{"key":"10.1016\/j.bbih.2026.101179_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2019.07.008","article-title":"Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury","volume":"497","author":"Zhang","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbih.2026.101179_bib65","article-title":"Fast maturation of splenic dendritic cells upon TBI is associated with FLT3\/FLT3L signaling","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:18:03Z","timestamp":1773976683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354626000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":65,"alternative-id":["S2666354626000128"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101179","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic inflammation and its associations in acute moderate-severe Traumatic Brain Injury: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101179"}}